Skip to content
Alzprotect SAS logo — Therapeutic Solutions for Neurodegeneration

Alzprotect SAS

Therapeutic Solutions for Neurodegeneration

Founded 2007 France France 12 employees Grant Total: $16.34M Biotechnology, Pharmaceutical

General Information

Company Name Alzprotect SAS
Founded Year 2007
Location France France
Employees 12
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Alzprotect SAS. To contact Alzprotect SAS, visit alzprotect.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alzprotect SAS compare?

A PDF of Alzprotect SAS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alzprotect SAS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alzprotect SAS

AlzProtect is a biopharmaceutical startup established in 2007, specializing in the development of drug candidates aimed at treating neurodegenerative diseases and rare tauopathies, including Alzheimer's disease and Progressive Supranuclear Palsy (PSP). The company's focus ranges from discovery to clinical trials, with the ultimate goal of providing solutions for these challenging conditions. Their latest funding round of $338.00K came in the form of a grant investment from the Michael J. Fox Foundation on 01 June 2022. With a strong commitment to pioneering drug development in this critical area, AlzProtect is positioned to make meaningful contributions to the field, bolstered by the support of esteemed investors.

Business keywords: biopharmaceutical company, drug development, neurodegenerative diseases, Alzheimer's disease, tauopathies, rare diseases, clinical trials, neuroscience research, pharmaceutical industry, biotech startups

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $338.00K 1
The Michael J. Fox Foundation for Parkinson's Research
01 Jun 2022
Series B €14.00M 1
Xerys Captial
22 Jan 2018
Series A €2.00M 2
Nord France Amorcage, Finovam Gestion
11 Jun 2014
Venture Round Undisclosed 1
FINORPA
01 Nov 2008
Non Equity Assistance Undisclosed 1
Eurasante
13 Feb 2007

Alzprotect SAS Alternatives & Competitors

View All Alternatives
Alzprotect SAS vs
Wren Therapeutics
Wren Therapeutics United Kingdom

Stopping the wave of neurodegeneration at its source

Venture round
34 employees
Biopharma, Biotechnology
Alzprotect SAS vs

Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative diseases.

Grant
13 employees
Biotechnology, Pharmaceutical
Alzprotect SAS vs
KeifeRx
KeifeRx United States

KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegenerative di...

Series A
7 employees
Biopharma, Biotechnology

FAQ About Alzprotect SAS

Therapeutic Solutions for Neurodegeneration
Alzprotect SAS was founded in 2007.
Alzprotect SAS is headquartered in France.
Alzprotect SAS operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical company, drug development, neurodegenerative diseases and Alzheimer's disease.
Alzprotect SAS has approximately 12 employees.
Alzprotect SAS has completed 5 funding rounds, raising a total of $16.34M. The latest funding stage is Grant.
Top alternatives and competitors to Alzprotect SAS include Wren Therapeutics, Cantabio Pharmaceuticals, Inc., KeifeRx, CaSRevolution, Neuraltus Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alzprotect SAS and Wren Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alzprotect SAS, https://bouncewatch.com/company/alzprotect, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout